RenovoRx (RNXT) Total Current Liabilities (2020 - 2026)

RenovoRx has disclosed Total Current Liabilities across 7 years of filings, most recently posting $1.9 million for Q2 2026.

• In Q2 2026, Total Current Liabilities rose 21.08% year-over-year to $1.9 million; the TTM figure through Jun 2026 stood at $1.9 million (up 21.08% YoY), while the FY2025 annual figure was $2.0 million, up 2.78% from the prior year.
• Total Current Liabilities came in at $1.9 million for Q2 2026 at RenovoRx, down from $1.9 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $2.0 million in Q4 2025 to a low of $1.1 million in Q1 2024.
• Average Total Current Liabilities over 5 years is $1.6 million, with a median of $1.7 million recorded in 2023.
• The largest YoY upside for Total Current Liabilities was 62.47% in 2024 against a maximum downside of 22.84% in 2024.
• Over 5 years, Total Current Liabilities stood at $1.1 million in 2022, then climbed by 6.62% to $1.2 million in 2023, then soared by 62.47% to $1.9 million in 2024, then gained by 2.78% to $2.0 million in 2025, then declined by 3.98% to $1.9 million in 2026.
• Per Business Quant data, the three most recent Total Current Liabilities figures were $1.9 million in Q2 2026, $1.9 million in Q1 2026, and $2.0 million in Q4 2025.